A detailed history of Alps Advisors Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Alps Advisors Inc holds 2,901 shares of NBIX stock, worth $364,510. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,901
Previous 2,491 16.46%
Holding current value
$364,510
Previous $342,000 2.63%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $46,977 - $62,791
410 Added 16.46%
2,901 $333,000
Q2 2024

Aug 13, 2024

SELL
$130.86 - $143.19 $1,962 - $2,147
-15 Reduced 0.6%
2,491 $342,000
Q1 2024

May 14, 2024

SELL
$130.4 - $143.74 $53,333 - $58,789
-409 Reduced 14.03%
2,506 $345,000
Q4 2023

Feb 14, 2024

SELL
$106.07 - $132.76 $17,501 - $21,905
-165 Reduced 5.36%
2,915 $384,000
Q3 2023

Nov 14, 2023

BUY
$94.02 - $117.1 $289,581 - $360,668
3,080 New
3,080 $346,000
Q3 2020

Nov 04, 2020

SELL
$96.16 - $135.15 $244,438 - $343,551
-2,542 Closed
0 $0
Q2 2020

Aug 05, 2020

SELL
$85.09 - $130.36 $23,995 - $36,761
-282 Reduced 9.99%
2,542 $310,000
Q1 2020

May 06, 2020

BUY
$75.11 - $113.76 $212,110 - $321,258
2,824 New
2,824 $244,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.